Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.
Zeng Z, Sarbassov dos D, Samudio IJ, Yee KW, Munsell MF, Ellen Jackson C, Giles FJ, Sabatini DM, Andreeff M, Konopleva M.
Zeng Z, et al. Among authors: sarbassov dos d.
Blood. 2007 Apr 15;109(8):3509-12. doi: 10.1182/blood-2006-06-030833. Epub 2006 Dec 19.
Blood. 2007.
PMID: 17179228
Free PMC article.